BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 32808889)

  • 1. Gadolinium Retention in the Central and Peripheral Nervous System: Implications for Pain, Cognition, and Neurogenesis.
    Alkhunizi SM; Fakhoury M; Abou-Kheir W; Lawand N
    Radiology; 2020 Nov; 297(2):407-416. PubMed ID: 32808889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadolinium Retention, Brain T1 Hyperintensity, and Endogenous Metals: A Comparative Study of Macrocyclic Versus Linear Gadolinium Chelates in Renally Sensitized Rats.
    Rasschaert M; Emerit A; Fretellier N; Factor C; Robert P; Idée JM; Corot C
    Invest Radiol; 2018 Jun; 53(6):328-337. PubMed ID: 29329151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats.
    Robert P; Violas X; Grand S; Lehericy S; Idée JM; Ballet S; Corot C
    Invest Radiol; 2016 Feb; 51(2):73-82. PubMed ID: 26606549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats: Difference Between Linear and Macrocyclic Agents.
    Robert P; Lehericy S; Grand S; Violas X; Fretellier N; Idée JM; Ballet S; Corot C
    Invest Radiol; 2015 Aug; 50(8):473-80. PubMed ID: 26107651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Evaluation of Gadolinium Retention in Rat Brain After Single Injection of a Clinically Relevant Dose of Gadolinium-Based Contrast Agents.
    Strzeminska I; Factor C; Robert P; Grindel AL; Comby PO; Szpunar J; Corot C; Lobinski R
    Invest Radiol; 2020 Mar; 55(3):138-143. PubMed ID: 31917763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats.
    Frenzel T; Apte C; Jost G; Schöckel L; Lohrke J; Pietsch H
    Invest Radiol; 2017 Jul; 52(7):396-404. PubMed ID: 28125438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-year Retention of Gadolinium in the Brain: Comparison of Gadodiamide and Gadoterate Meglumine in a Rodent Model.
    Robert P; Fingerhut S; Factor C; Vives V; Letien J; Sperling M; Rasschaert M; Santus R; Ballet S; Idée JM; Corot C; Karst U
    Radiology; 2018 Aug; 288(2):424-433. PubMed ID: 29786486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Age Interfere With Gadolinium Toxicity and Presence in Brain and Bone Tissues?: A Comparative Gadoterate Versus Gadodiamide Study in Juvenile and Adult Rats.
    Fretellier N; Granottier A; Rasschaert M; Grindel AL; Baudimont F; Robert P; Idée JM; Corot C
    Invest Radiol; 2019 Feb; 54(2):61-71. PubMed ID: 30394964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
    Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
    Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Speciation Analysis of Residual Gadolinium in Deep Cerebellar Nuclei in Rats Repeatedly Administered With Gadoterate Meglumine or Gadodiamide.
    Strzeminska I; Factor C; Jimenez-Lamana J; Lacomme S; Subirana MA; Le Coustumer P; Schaumlöffel D; Robert P; Szpunar J; Corot C; Lobinski R
    Invest Radiol; 2022 May; 57(5):283-292. PubMed ID: 35066532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadolinium Presence in the Brain After Administration of the Liver-Specific Gadolinium-Based Contrast Agent Gadoxetate: A Systematic Comparison to Multipurpose Agents in Rats.
    Jost G; Frenzel T; Boyken J; Schoeckel L; Pietsch H
    Invest Radiol; 2019 Aug; 54(8):468-474. PubMed ID: 30932931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Speciation Analysis of Gadolinium in the Water-Insoluble Rat Brain Fraction After Administration of Gadolinium-Based Contrast Agents.
    Strzeminska I; Factor C; Robert P; Szpunar J; Corot C; Lobinski R
    Invest Radiol; 2021 Sep; 56(9):535-544. PubMed ID: 33813574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting the Pharmacokinetic Profiles of Gadolinium-Based Contrast Agents: Differences in Long-Term Biodistribution and Excretion.
    Lancelot E
    Invest Radiol; 2016 Nov; 51(11):691-700. PubMed ID: 27175546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadolinium Retention in Erythrocytes and Leukocytes From Human and Murine Blood Upon Treatment With Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging.
    Di Gregorio E; Furlan C; Atlante S; Stefania R; Gianolio E; Aime S
    Invest Radiol; 2020 Jan; 55(1):30-37. PubMed ID: 31503081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadolinium retention in gliomas and adjacent normal brain tissue: association with tumor contrast enhancement and linear/macrocyclic agents.
    Kiviniemi A; Gardberg M; Ek P; Frantzén J; Bobacka J; Minn H
    Neuroradiology; 2019 May; 61(5):535-544. PubMed ID: 30710184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term Excretion of Gadolinium-based Contrast Agents: Linear versus Macrocyclic Agents in an Experimental Rat Model.
    Jost G; Frenzel T; Boyken J; Lohrke J; Nischwitz V; Pietsch H
    Radiology; 2019 Feb; 290(2):340-348. PubMed ID: 30422091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadolinium Retention and Clearance in the Diabetic Brain after Administrations of Gadodiamide, Gadopentetate Dimeglumine, and Gadoterate Meglumine in a Rat Model.
    Wang ST; Hua ZX; Fan DX; Zhang X; Ren K
    Biomed Res Int; 2019; 2019():3901907. PubMed ID: 31192255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of Gd in the protein content of the brain following single injection of gadolinium-based contrast agents (GBCAs) by size exclusion chromatography.
    Kartamihardja AAP; Hanaoka H; Andriana P; Kameo S; Takahashi A; Koyama H; Tsushima Y
    Br J Radiol; 2019 Jul; 92(1099):20190062. PubMed ID: 31045442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gadolinium Deposition in the Brain in a Large Animal Model: Comparison of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
    Radbruch A; Richter H; Fingerhut S; Martin LF; Xia A; Henze N; Paulus W; Sperling M; Karst U; Jeibmann A
    Invest Radiol; 2019 Sep; 54(9):531-536. PubMed ID: 31261291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Gadolinium Distribution of the New High-Relaxivity Gadolinium Chelate Gadopiclenol in a Rat Model of Severe Renal Failure.
    Fretellier N; Rasschaert M; Bocanegra J; Robert P; Factor C; Seron A; Idée JM; Corot C
    Invest Radiol; 2021 Dec; 56(12):826-836. PubMed ID: 34091462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.